Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.

Rather than acknowledge the harm caused by such facilities, activists are attempting to slander the victims You can save this article by registering for free here. Or sign-in if you have an account.

BAGSVÆRD, Denmark and PLAINSBORO, N.J., Sept. 29, 2025 /PRNewswire/ -- Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration ...

In September 2025, Merck received FDA approval for KEYTRUDA QLEX, a subcutaneous version of its flagship cancer therapy, allowing for one- to two-minute administration across 38 solid tumor ...

A used needle is seen on the ground on Friday, March 22, 2024, in Baker Park in Grants Pass, Ore. The two candidates vying to represent District 7 on Boston City Council have different opinions about ...

The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis. With ...

The Boston City Council struck down a resolution opposing safe injection sites, with proponents rejecting notions that legalizing such centers would incentivize addicts to shoot up and saying that ...

A drug dealer who sold fentanyl outside a drug consumption site has pleaded guilty to manslaughter in connection with an east end shooting that killed a bystander two years ago. According to an agreed ...

One of three men involved in a deadly gunfight that killed an innocent bystander outside the Leslieville safe injection site more than two years ago has pleaded guilty to manslaughter. The surprise ...

Patients can now receive treatment in as little as one to two minutes, compared to a 30-minute IV infusion New option offers greater convenience and flexibility in treatment settings, from hospitals ...

Tremfya is now the first and only fully subcutaneous IL-23 inhibitor approved to treat both ulcerative colitis and Crohn’s disease. The FDA has approved a subcutaneous injection induction regimen of ...